Skip to results
Modify your search
NARROW
1-18 of 18
Authors: Michael D Hughes
Journal Article
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Clinical Infectious Diseases, ciaf029, https://doi.org/10.1093/cid/ciaf029
Published: 17 February 2025
Journal Article
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19 Get access
Clinical Infectious Diseases, Volume 79, Issue 4, 15 October 2024, Pages 920–927, https://doi.org/10.1093/cid/ciae324
Published: 17 July 2024
Journal Article
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries Get access
Clinical Infectious Diseases, Volume 80, Issue 1, 15 January 2025, Pages 137–143, https://doi.org/10.1093/cid/ciae269
Published: 13 May 2024
Journal Article
EDITOR'S CHOICE
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester
Clinical Infectious Diseases, Volume 78, Issue 3, 15 March 2024, Pages 667–673, https://doi.org/10.1093/cid/ciad583
Published: 28 September 2023
Journal Article
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial
Clinical Infectious Diseases, Volume 77, Issue 7, 1 October 2023, Pages 941–949, https://doi.org/10.1093/cid/ciad342
Published: 05 June 2023
Journal Article
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, Volume 77, Issue 6, 15 September 2023, Pages 892–900, https://doi.org/10.1093/cid/ciad301
Published: 25 May 2023
Journal Article
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019
Clinical Infectious Diseases, Volume 76, Issue 4, 15 February 2023, Pages 734–737, https://doi.org/10.1093/cid/ciac818
Published: 10 October 2022
Journal Article
Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral Suppression
Clinical Infectious Diseases, Volume 73, Issue 4, 15 August 2021, Pages e997–e1003, https://doi.org/10.1093/cid/ciab143
Published: 19 February 2021
Journal Article
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life
Clinical Infectious Diseases, Volume 72, Issue 3, 1 February 2021, Pages 388–393, https://doi.org/10.1093/cid/ciaa028
Published: 12 January 2020
Journal Article
Diverse Human Immunodeficiency Virus–1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings
Clinical Infectious Diseases, Volume 71, Issue 7, 1 October 2020, Pages e170–e177, https://doi.org/10.1093/cid/ciz1116
Published: 14 November 2019
Journal Article
Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial
Clinical Infectious Diseases, Volume 70, Issue 11, 1 June 2020, Pages 2317–2324, https://doi.org/10.1093/cid/ciz634
Published: 27 July 2019
Journal Article
EDITOR'S CHOICE
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals
Clinical Infectious Diseases, Volume 69, Issue 3, 1 August 2019, Pages 514–522, https://doi.org/10.1093/cid/ciy913
Published: 28 March 2019
Journal Article
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease
Clinical Infectious Diseases, Volume 70, Issue 3, 1 February 2020, Pages 425–435, https://doi.org/10.1093/cid/ciz235
Published: 28 March 2019
Journal Article
EDITOR'S CHOICE
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor–based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials
Clinical Infectious Diseases, Volume 63, Issue 2, 15 July 2016, Pages 268–280, https://doi.org/10.1093/cid/ciw236
Published: 18 April 2016
Journal Article
Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens Get access
Clinical Infectious Diseases, Volume 59, Issue 6, 15 September 2014, Pages 888–896, https://doi.org/10.1093/cid/ciu367
Published: 19 May 2014
Journal Article
Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy Get access
Clinical Infectious Diseases, Volume 57, Issue 2, 15 July 2013, Pages 290–297, https://doi.org/10.1093/cid/cit195
Published: 26 March 2013
Journal Article
Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV Get access
Clinical Infectious Diseases, Volume 56, Issue 7, 1 April 2013, Pages 1044–1051, https://doi.org/10.1093/cid/cis1219
Published: 08 January 2013
Journal Article
Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211 Get access
Clinical Infectious Diseases, Volume 48, Issue 5, 1 March 2009, Pages 642–649, https://doi.org/10.1086/597007
Published: 01 March 2009
